Novus Biologicals™ Recombinant Human HLA DRA His Protein

Description

Highly purified. Generating reliable and reproducible results.

A recombinant protein with a N-Terminal His-tag and corresponding to the amino acids 26-216 of Human HLA DRA The Recombinant Human HLA DRA Protein is derived from E. coli. The Recombinant Human HLA DRA Protein has been validated for the following applications: SDS-Page.

Specifications

• Concentration: 0.5mg/mL
• For Use With (Application): SDS-PAGE
• Formulation: 20mM Tris-HCl buffer (pH 8.0) containing 0.15M NaCl, 10% glycerol, 1mM DTT
• Gene ID (Entrez): 3122
• Molecular Weight (g/mol): TMW: 24.3kDa
• Quantity: 0.5 mg
• Storage Requirements: Store at 4°C short term. Aliquot and store at −20°C long term. Avoid freeze-thaw cycles.
• Gene Alias: FLJ51114, histocompatibility antigen HLA-DR alpha, HLA class II histocompatibility antigen, DR alpha chain, HLA-DRA1, major histocompatibility complex, class II, DR alpha, MHC cell surface glycoprotein, MHC class II antigen DRA, MLRW
• Common Name: HLA DRA
• Conjugate: Unconjugated
• Recombinant: Recombinant
• Purity or Quality Grade: >90%, by SDS-PAGE under reducing conditions and visualized by Colloidal Coomassie™ Blue stain

For research use only and is not approved for use in humans or in clinical diagnosis